Good news feed

Today’s constructive developments

167

published good-news items

active open sources

See sources and usage notes →

Your personal paper

Pick your interests and we will tune the feed.

Personal feed: Health

Unseen All stories Seen archive

+HealthThe Guardian UK· Jun 11, 11:01 PM

Lupus patients in England in remission after pioneering NHS trial of GM therapy

Five lupus patients in England achieved remission using CAR T-cell therapy, which genetically modifies their own immune cells. This breakthrough treatment could offer a potential cure for the chronic autoimmune disease.

Why good news?

Patients achieving remission represents a concrete medical breakthrough for autoimmune diseases. Using a patient's own modified cells to reset their immune system demonstrates significant scientific progress.

Why it matters?

Lupus and similar autoimmune diseases significantly impact quality of life. Success with this therapy could offer hope to millions of autoimmune disease patients worldwide.

Open analysis Read source →

+HealthBBC UK· Jun 11, 03:00 PM

Weight-loss drug Wegovy to be available in pill form in UK for first time

Weight-loss drug Wegovy will be available in pill form in the UK for the first time. The new formulation offers a more convenient option for some patients compared to weekly injections.

Why good news?

Diversifying treatment options improves accessibility for patients. Providing an alternative for those uncomfortable with injections or preferring tablets can enhance treatment adherence and patient satisfaction.

Why it matters?

Obesity and weight management are significant public health concerns. Expanding treatment options enables more people to access suitable methods for managing their health.

Open analysis Read source →

+HealthThe Guardian UK· Jun 7, 02:12 PM

NHS hospitals adopt faster, more accurate at-home bladder cancer test

Five NHS hospitals in England and Wales have adopted a new at‑home urine test for bladder cancer diagnosis. The test is faster, more accurate and more comfortable for patients.

Why good news?

Patients avoid uncomfortable invasive procedures and receive quicker, more accurate diagnoses, enabling earlier treatment.

Why it matters?

Early detection is critical for cancer outcomes; this innovation improves patient experience and boosts healthcare system efficiency.

Open analysis Read source →

+HealthBBC UK· Jun 10, 05:06 PM

Vets advise ban on over the counter flea treatment for pets

Veterinarians are advising a ban on over-the-counter flea treatments for pets. Pet owners have historically been advised to apply preventative treatments monthly.

Why good news?

Veterinary guidance toward regulated treatment encourages more informed pet care and reduces unnecessary medication use. This approach supports animal welfare and helps combat antimicrobial resistance concerns.

Why it matters?

Professional-guided pet treatment ensures personalized care based on actual needs and helps reduce antibiotic/antimicrobial resistance—a significant public health concern.

Open analysis Read source →

+HealthThe Guardian UK· Jun 7, 09:16 AM

Triple-action diabetes jab shown to reduce blood sugar and body weight

A new weekly injection called retatrutide for type 2 diabetes has shown significant results in phase 3 trials, reducing blood sugar and body weight substantially. Patients lost over four times more weight and achieved more than twice the blood sugar reduction compared to placebo.

Why good news?

Offers a new and effective treatment option for diabetes management. By working through three hormone mechanisms simultaneously, it provides a more comprehensive approach to appetite control, blood sugar, and metabolism compared to existing medications.

Why it matters?

Type 2 diabetes affects millions globally. More effective treatments are crucial for improving patient quality of life and preventing serious complications.

Open analysis Read source →

+HealthThe Guardian UK· Jun 9, 07:28 AM

GSK to buy US cancer treatment firm Nuvalent for $10.6bn

British drugmaker GSK acquires US cancer specialist Nuvalent for $10.6bn to strengthen its oncology portfolio. The deal includes late-stage medications for lung cancer treatment.

Why good news?

Increased investment in cancer treatment development can accelerate drug innovation and expand patient treatment options. More therapeutic alternatives for serious diseases like lung cancer are becoming available.

Why it matters?

Cancer research and treatment are among global health priorities. Major pharmaceutical investments in this field increase the likelihood of developing new therapeutic solutions.

Open analysis Read source →

+HealthThe Guardian UK· Jun 11, 03:33 PM

Wegovy weight-loss pills to be available for patients in UK to buy

The UK has approved Wegovy weight-loss pills for patient purchase with private prescription. The MHRA authorization makes the UK the third country to approve this GLP-1 receptor agonist tablet after the US and UAE.

Why good news?

A new treatment option for obesity becomes legally accessible, expanding healthcare choices for patients with weight-related health conditions. Regulatory approval indicates the medication meets safety and efficacy standards.

Why it matters?

Obesity is linked to serious health conditions including cardiovascular disease and diabetes. New treatment options have potential to improve quality of life and health outcomes.

Open analysis Read source →